RT Journal Article
SR Electronic
T1 Accessioning and automation compatible anterior nares swab design
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.24.20200386
DO 10.1101/2020.09.24.20200386
A1 Pettit, Mary E.
A1 Boswell, Sarah A.
A1 Qian, Jason
A1 Novak, Richard
A1 Springer, Michael
YR 2020
UL http://medrxiv.org/content/early/2020/09/25/2020.09.24.20200386.abstract
AB The COVID-19 pandemic has resulted in an unparalleled need for viral testing capacity across the world and is a critical requirement for successful re-opening of economies. The logistical barriers to near-universal testing are considerable. We have designed an injection molded polypropylene anterior nares swab, the RHINOstick, with a screw cap integrated into the swab handle that is compatible with fully automated sample accessioning and processing. The ability to collect and release both human and viral material is comparable to that of several commonly used swabs on the market. SARS-CoV-2 is stable on dry RHINOstick swabs for at least 3 days, even at 42°C, and elution can be achieved with small volumes. The swab and barcoded tube set can be produced, sterilized, and packaged at < 2 USD per unit and can easily be adopted by large research institutes to increase throughput and dramatically reduce the cost of a standard SARS-CoV-2 detection pipeline.Competing Interest StatementRichard Novak and Michael Springer are launching a company, RHINOstick Inc., to commercialize the swabs described in this paperFunding StatementDARPA D18AC00006 supported this grant Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The work in this manuscript is covered by IRB20-0581All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data will be included in the supplementary material of the manuscript.